Published in AIDS Weekly, May 24th, 2010
Gross profit was $2.9 million (19.7% gross margin), compared to $2.7 million (21.5% gross margin) in the first quarter last year.
Operating expenses as a percentage of sales declined 400 basis points to 15.7% from 19.7% in the year-ago period.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.